IRCT20220313054264N1 IRCT 2022-06-12 Iran University of Medical Sciences A comparative study of CGRP neuropeptide levels in patients with endometriosis pain treated with dienogest A comparative study of CGRP neuropeptide levels in patients with endometriosis pain treated with dienogest 2022-04-03 anticipated 10 Complete https://irct.ir/trial/62456 interventional Randomization: N/A, Blinding: Not blinded, Placebo: Not used, Assignment: Single, Purpose: Basic scienece. 3 endometriosis. Intervention group: Patients with endometriosis with pain, according to the doctor's diagnosis for drug treatment of pain Dinogen 2 mg per day orally (tablets) (Iran Hormone Company) once a day for 6 months and assess pain and level The CGRP marker is evaluated before and after taking the drug.. Yes - There is a plan to make this available What will be shared: Part of data like the main outcome or the same will be shared When: Access after 6 months after publication To whom: Data will be available for all researchers Conditions: It is important for further research and identification of markers in reducing patients' pain that can be used later in the pharmaceutical industry. Where to obtain: For receiving data please be contacted with ajdari.m@iums.ac.ir How to obtain: limitless Comments: